IPSC position history
The shares of Century Therapeutics (IPSC) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 80,000 shares, $2M, 0.53% of portfolio
- 2021 Q4: 100,135 shares, $1.6M, 0.40% of portfolio, Add +25.2%
- 2022 Q1: 256,892 shares, $3.2M, 0.84% of portfolio, Add +156.5%
- 2022 Q2: 475,367 shares, $4M, 1.1% of portfolio, Add +85.0%
- 2022 Q3: 475,367 shares, $4.7M, 1.3% of portfolio
- 2022 Q4: 475,367 shares, $2.4M, 0.69% of portfolio
- 2023 Q1: 1,307,407 shares, $4.5M, 1.4% of portfolio, Add +175.0%
- 2023 Q2: 1,307,407 shares, $4.1M, 1.1% of portfolio
- 2023 Q3: 1,307,407 shares, $2.6M, 0.81% of portfolio
- 2023 Q4: 1,307,407 shares, $4.3M, 1.0% of portfolio
- 2024 Q1: 1,307,407 shares, $5.5M, 1.2% of portfolio
- 2024 Q2: 1,704,232 shares, $4.3M, 1.0% of portfolio, Add +30.4%
- 2024 Q3: 1,704,232 shares, $2.9M, 0.69% of portfolio
- 2024 Q4: 1,704,232 shares, $1.7M, 0.44% of portfolio
- 2025 Q1: 1,704,232 shares, $811K, 0.23% of portfolio
- 2025 Q2: 1,704,232 shares, $952K, 0.26% of portfolio
- 2025 Q3: 1,704,232 shares, $849K, 0.21% of portfolio
- 2025 Q4: 2,793,586 shares, $2.8M, 0.65% of portfolio, Add +63.9%
- 2026 Q1: 2,434,353 shares, $5.5M, 1.3% of portfolio, Reduce −12.9%
- 2026 Q2: 2,400,458 shares, $5.9M, 1.1% of portfolio, Reduce −1.4%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|